Sepsis - Glycemic Control Flashcards
Intensive Insulin Therapy in SICU Study 2001
SICU patients
Glucose <200
Lower group had 32% reduced ICU and in-hospital mortality
Intensive Insulin Therapy in MICU Study 2006
Pts expected to be in ICU >=3days
If actually in ICU >=3d, in-hospital mortality reduced by 18% for glucose <110
No difference in mortality in the aggregate groups
NICE-SUGAR
NEJM 2009
6000 MICU & SICU pts, international, expected ICU stay >=3d
Intensive group target Gluc81-108 had higher 90-d mortality than group targeting <180
COIITS
JAMA 2010
ICU pts on steroids randomized to 80-100 vs 180-200
No difference in mortality, ICU stay, ventilator free days, or pressor free days
Current recommendations for glycemic control in ICU pts
Optimal range is in flux, but recommend 140-180
BHIP Results
Mean glucose 144 with <40
Should NOT be used for DKA/HHS
Factors to determine when to transition pts from BHIP to SC
- HD stability
- Dietary stability
- Pending surgical or invasive procedures
Insulin SC components to switch to from BHIP
- Basal insulin: NPH or Lantus
- QAC insulin: Regular if TFs, Aspart if POs
- ISS (regular or aspart pending TFs vs POs)
Dose conversion from BHIP to SC
- Total daily dose of BHIP = avg insulin gtt for past 6-12 hrs x 24h
- Corrected TDD = 0.6 * TDD
- Give 50% of CTDD as basal, 50% as nutritional. If NPO, give all CTDD as basal
- ISS based on CTDD (80 = high)
- Stop insulin gtt 1-2h AFTER 1st dose of nutritional insulin or 2h after 1st dose of basal